搜尋結果

共 2023 個結果
頁數:1...45 46 47 48 49 50 51 52 53 ...102

開拓藥業-B(09939) 其他-業務發展最新情況

開拓藥業-B(09939) 自願公告 普克魯胺治療COVID-19重症患者的臨床試驗結果(140KB, pdf ...全文

即時新聞港交所通告2021年03月11日

Time for government to set up Science and Development Office

Even though the city has prioritised economic development for decades, the changing needs as a result of the pandemic mean Hong Kong should strengthen its policy on science by establishing a high-leve ...More

EJ Insight2021-03-10

The US recovery’s promising moment

President Joe Biden’s announcement that the US will have enough COVID-19 vaccines for every American by the end of May has contributed to a rising tide of optimism about the country’s economic prospec ...More

EJ Insight2021-03-10

The bitcoin lottery

I was recently approached about setting up my own “special purpose acquisition company” (SPAC), which would allow me to secure financial commitments from investors on the expectation that I will event ...More

EJ Insight2021-03-09

On vaccine politics, public communication and political efficacy

The vaccine is political. To put it bluntly, the medica ...全文

今日信報時事評論EJ InsightBrian2021年03月09日

On vaccine politics, public communication and political efficacy

The vaccine is political. To put it bluntly, the medical is political. The recent rollout of vaccines across Hong Kong has been marred by plenty of unfortunate ‘events’ – intermittent in their frequen ...More

EJ Insight2021-03-08

Data infrastructure fundamental to HK's innotech development

On Hong Kong’s latest Budget, I would like to comment from the following aspects of the innovation and technology (innotech): 1) Nurturing I&T talent The programs including “Knowing More About IT” ...More

EJ Insight2021-03-08

大嶼山人想要怎樣的明日大嶼?

「明日大嶼」5.5億元的前期研究撥款毫無懸念地在民主派全體出缺的情況下通過,標誌着整個計劃發展已經踏入另一個階 ...全文

今日信報時事評論龍子維2021年03月08日

從疫苗到通脹看科技股大跌

自新冠疫情爆發以來,世界各個藥廠便爭相開發疫苗,結果以創紀錄的時間在去年成功研製,今年開始全面使用。有趣的是, ...全文

今日信報理財投資財經coffee陸永2021年03月06日

開拓藥業-B(09939) 其他-業務發展最新情況

開拓藥業-B(09939) 自願公告 普克魯胺治療COVID-19的III期臨床試驗獲美國食品和藥物管理局(F ...全文

即時新聞港交所通告2021年03月05日

小兒麻痹症的啟示(下)

小兒麻痹症以攻擊脊椎的神經元來阻擋中樞神經系統與肌肉的傳遞,導致患者窒息,與我們現在經歷的COVID-19攻擊 ...全文

今日信報副刊文化視線所及李衍蒨2021年03月03日

英國解鎖時間表

歐盟國家不單為成員國國民注射疫苗慢吞吞,消息傳來,意大利北部Lombardy、Piedmont等地區又再次局部 ...全文

今日信報副刊文化酒食浪遊劉群章2021年03月03日

New round of jab bookings

In the latest round of jab arrangement, citizens in the priority groups can make online bookings to receive the COVID-19 vaccine from March 3, the Government said Monday. They can arrange to receive t ...More

EJ Insight2021-03-02

Realizing the silver lining of the pandemic

In “The Great Realisation,” a compelling four-minute video, the poet Tomos Roberts (aka Tom Foolery) suggests a potential silver lining to the COVID-19 cataclysm. By forcing us to slow down, literally ...More

EJ Insight2021-03-02

為何美國應該追求與華合作

二次世界大戰以來,美國外交政策一直基於一個簡單的概念,小布殊總統在2001年9月11日恐怖襲擊後的講話中最清楚 ...全文

今日信報時事評論Jeffrey D. Sachs2021年03月02日

Winning the COVID vaccination race: India’s case

As the world enters the second year of the coronavirus pandemic, vaccination has moved front and center in policymakers’ responses. But while vaccines offer the surest way out of the crisis, countries ...More

EJ Insight2021-03-01

一危俱危

G7最近認識到「一危俱危」,宣布採取更多措施幫助全球「更加平價和平等地獲得疫苗、治療和診斷」,以抗擊COVID ...全文

今日信報時事評論埃利安2021年02月27日

緬甸軍事政變後的中緬關係

2月中旬,緬甸最大城市仰光有群眾上街示威,抗議軍方拘捕去年11月大選勝出的國務資政昂山素姬、總統溫敏和其他「全 ...全文

今日信報時事評論黃伯農2021年02月27日

抗疫體現大國擔當

首批100萬劑由內地研發和生產的科興新冠疫苗2月中順利運抵香港,優先組別的市民可以網上預約接種疫苗。顧問專家委 ...全文

今日信報時事評論周伯展2021年02月27日

Telling the fortune of digital payments in 2021

Just over one year into the COVID-19 pandemic, it has been impossible to ignore the stratospheric growth of digital payment methods across the world. In APAC specifically, we’ve seen Facebook and PayP ...More

EJ Insight2021-02-26

頁數:1...45 46 47 48 49 50 51 52 53 ...102

信報簡介 | 服務條款 | 私隱條款 | 免責聲明 | 廣告查詢 | 加入信報 | 聯絡信報

股票及指數資料由財經智珠網有限公司提供。期貨指數資料由天滙財經有限公司提供。外滙及黃金報價由路透社提供。

本網站的內容概不構成任何投資意見,本網站內容亦並非就任何個別投資者的特定投資目標、財務狀況及個別需要而編製。投資者不應只按本網站內容進行投資。在作出任何投資決定前,投資者應考慮產品的特點、其本身的投資目標、可承受的風險程度及其他因素,並適當地尋求獨立的財務及專業意見。本網站及其資訊供應商竭力提供準確而可靠的資料,但並不保證資料絕對無誤,資料如有錯漏而令閣下蒙受損失,本公司概不負責。